Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Phone31-20-420-3191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$700.84 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date4/24/2019 (Estimated)
OptionableOptionable
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories announced a quarterly dividend on Wednesday, January 16th. Shareholders of record on Friday, January 25th will be given a dividend of $0.55 per share on Friday, February 15th. This represents a $2.20 annualized dividend and a dividend yield of 3.42%. The ex-dividend date of this dividend is Thursday, January 24th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) issued its quarterly earnings results on Wednesday, January, 30th. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by $0.01. The oil and gas company earned $173.20 million during the quarter, compared to the consensus estimate of $173.90 million. Core Laboratories had a net margin of 11.35% and a return on equity of 63.86%. Core Laboratories's revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.58 EPS. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 30th. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the Thomson Reuters consensus estimate of $0.42. The company issued revenue guidance of $164-168 million, compared to the consensus revenue estimate of $165.34 million.Core Laboratories also updated its Q1 2019 guidance to $0.42-0.45 EPS.
What price target have analysts set for CLB?
14 Wall Street analysts have issued 1 year price objectives for Core Laboratories' stock. Their forecasts range from $66.00 to $130.00. On average, they expect Core Laboratories' stock price to reach $90.90 in the next year. This suggests a possible upside of 41.5% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Has Core Laboratories been receiving favorable news coverage?
News headlines about CLB stock have been trending positive on Friday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Core Laboratories earned a news impact score of 2.3 on InfoTrie's scale. They also assigned media coverage about the oil and gas company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the company's share price in the near future.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), Propetro (PUMP), Franks International (FI), SemGroup (SEMG), C&J Energy Services (CJ), FTS International (FTSI), Keane Group (FRAC), Helix Energy Solutions Group (HLX), Mammoth Energy Services (TUSK), Select Energy Services (WTTR), Superior Energy Services (SPN) and National Energy Services (NESR).
What other stocks do shareholders of Core Laboratories own?
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
- Mr. Monty L. Davis, COO & Sr. VP (Age 65)
- Mr. Richard L. Bergmark, Exec. VP (Age 66)
- Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 59)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (11.11%), BlackRock Inc. (7.41%), Massachusetts Financial Services Co. MA (5.90%), Kayne Anderson Rudnick Investment Management LLC (3.13%), Epoch Investment Partners Inc. (2.64%) and Millennium Management LLC (1.80%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
CLB stock was sold by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Kayne Anderson Rudnick Investment Management LLC, Wedgewood Partners Inc., Epoch Investment Partners Inc., Bank of America Corp DE, Macquarie Group Ltd., Raymond James & Associates and Prudential Financial Inc.. View Insider Buying and Selling for Core Laboratories.
Which institutional investors are buying Core Laboratories stock?
CLB stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Millennium Management LLC, Van ECK Associates Corp, Dimensional Fund Advisors LP, Mairs & Power INC, UBS Oconnor LLC, UBS Oconnor LLC and Fisher Asset Management LLC. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $64.25.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $2.85 billion and generates $700.84 million in revenue each year. Core Laboratories employs 4,700 workers across the globe.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
